Renba Liang

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Epidermal Growth Factor Receptor

Monoclonal Antibody

Small Cell Lung Cancer

Top Venues

Cancer control : journal of the Moffitt Cancer Center

Technology in cancer research & treatment

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Yuelan Qin, Renba Liang, Pingan Lu, Lin Lai, Xiao-Dong Zhu
Depicting the Implication of miR-378a in Cancers. Technology in cancer research & treatment 21 (2022)
Lin Lai, Xinyu Chen, Ge Tian, Renba Liang, Xishan Chen, Yuelan Qin, Kaihua Chen, Xiaodong Zhu
Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics. Cancer control : journal of the Moffitt Cancer Center 29 (2022)
Renba Liang, Liu Yang, Xiaodong Zhu
Nimotuzumab, an Anti-EGFR Monoclonal Antibody, in the Treatment of Nasopharyngeal Carcinoma. Cancer control : journal of the Moffitt Cancer Center 28 (2021)
Renba Liang
Letter to the editor Re: Pan et al. "LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer". Breast cancer research and treatment 184 (2) (2020)